Invesaro

Stocks Comparison

Quest Diagnostics vs RadNet: revenue, profit, margins and growth compared

Quest Diagnostics brought in $11B of revenue in fiscal 2025, RadNet $2B in fiscal 2025. Revenue changed by +11.8% at Quest Diagnostics and +11.5% at RadNet on the year before, so Quest Diagnostics grew faster. Quest Diagnostics kept 9.0% of its revenue as net profit, RadNet -0.9%.

Side by side, latest fiscal year

DGXRDNT
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$11B$2B
Revenue growth+11.8%+11.5%
Net income$992M-$18.7M
Net margin9.0%-0.9%
Free cash flow$1.4Bn/a
Free cash flow margin12.3%n/a
Earnings per share (diluted)$8.75-$0.25
Cash$420M$767.2M
Debt$5.7B$1.1B
Price to earnings27.0n/a
Market value$26.1B$5.6B
Dividend yieldn/an/a
Rank by revenue in sector#43 of 523 · Health care#108 of 523 · Health care

Over the years

Revenue
DGX FY2018: $7.5BDGX FY2019: $7.7BDGX FY2020: $9.4BDGX FY2021: $10.8BDGX FY2022: $9.9BDGX FY2023: $9.3BDGX FY2024: $9.9BDGX FY2025: $11BRDNT FY2018: $975.1MRDNT FY2019: $1.2BRDNT FY2020: $1.1BRDNT FY2021: $1.3BRDNT FY2022: $1.4BRDNT FY2023: $1.6BRDNT FY2024: $1.8BRDNT FY2025: $2BFY18FY19FY20FY21FY22FY23FY24FY25
DGX $11BRDNT $2B
Net income
DGX FY2018: $736MDGX FY2019: $858MDGX FY2020: $1.4BDGX FY2021: $2BDGX FY2022: $946MDGX FY2023: $854MDGX FY2024: $871MDGX FY2025: $992MRDNT FY2018: $32.2MRDNT FY2019: $14.8MRDNT FY2020: -$14.8MRDNT FY2021: $24.7MRDNT FY2022: $10.7MRDNT FY2023: $3MRDNT FY2024: $2.8MRDNT FY2025: -$18.7MFY18FY19FY20FY21FY22FY23FY24FY25
DGX $992MRDNT -$18.7M
Net margin
DGX FY2018: 9.8%DGX FY2019: 11.1%DGX FY2020: 15.2%DGX FY2021: 18.5%DGX FY2022: 9.6%DGX FY2023: 9.2%DGX FY2024: 8.8%DGX FY2025: 9.0%RDNT FY2018: 3.3%RDNT FY2019: 1.3%RDNT FY2020: -1.4%RDNT FY2021: 1.9%RDNT FY2022: 0.7%RDNT FY2023: 0.2%RDNT FY2024: 0.2%RDNT FY2025: -0.9%FY18FY19FY20FY21FY22FY23FY24FY25
DGX 9.0%RDNT -0.9%
Revenue growth
DGX FY2019: +2.6%DGX FY2020: +22.1%DGX FY2021: +14.3%DGX FY2022: -8.4%DGX FY2023: -6.4%DGX FY2024: +6.7%DGX FY2025: +11.8%RDNT FY2019: +18.4%RDNT FY2020: -7.1%RDNT FY2021: +22.7%RDNT FY2022: +8.7%RDNT FY2023: +13.0%RDNT FY2024: +13.2%RDNT FY2025: +11.5%FY19FY20FY21FY22FY23FY24FY25
DGX +11.8%RDNT +11.5%
Free cash flow
DGX FY2018: $817MDGX FY2019: $843MDGX FY2020: $1.6BDGX FY2021: $1.8BDGX FY2022: $1.3BDGX FY2023: $864MDGX FY2024: $909MDGX FY2025: $1.4BRDNT FY2018: $44.6MRDNT FY2019: $30.2MFY18FY19FY20FY21FY22FY23FY24FY25
DGX $1.4BRDNT $30.2M

Fiscal years as each company reports them; the two may end in different months.

Questions about Quest Diagnostics and RadNet

Which is bigger by revenue, Quest Diagnostics or RadNet?

Quest Diagnostics is bigger by revenue: $11B in fiscal 2025, against $2B for RadNet in fiscal 2025.

Which keeps more of its revenue as profit, Quest Diagnostics or RadNet?

Quest Diagnostics had a net margin of 9.0% in fiscal 2025; RadNet had -0.9% in fiscal 2025.

Which grew revenue faster, Quest Diagnostics or RadNet?

In their latest fiscal years revenue changed by +11.8% at Quest Diagnostics and +11.5% at RadNet.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies